Introduction
The packing and organization of genomes into chromosomes is central to the maintenance and transmission of genes during evolution 1 . In eukaryotes, ploidy (defined as the number of chromosome sets, n, of each cell) can range from a haploid genome n = 1 chromosome in the male of the Jack jumper ant (Myrmecia pilosula) 2 to a staggering~1,900 × n =~15,600 chromosomes (29.64 × 10 6 chromosomes) in the ciliated protozoan Oxytricha trifallax 3 . However, within mammals, the large majority of species maintain a diploid (2n) organization for most somatic cells and a haploid (n) status for gametes; an exception being made by the tetraploid viscacha rat Tympanoctomys barrerae 4 . The somatic/diploid and germline/haploid configuration is beneficial and enables genetic variation to be increased through sexual reproduction 5 , while conferring protection from deleterious mutations in the long-lived somatic tissues by allowing the presence of back-up alleles as well as providing a template for DNA damage repair 6 . Thus, to maintain normal physiology, mammalian cells have developed mechanisms that act throughout the cell cycle to prevent the occurrence of cells with abnormal chromosome numbers (aneuploid or polyploid) 7 , as these are a hallmark of genomic instability, and oncogenic transformation 8 . Most somatic cells maintain their diploid chromosome number through mitotic division, although non-oncogenic mosaic polyploidy can happen in selected tissues during development (e.g., placenta) or in adult life (e.g., liver, muscle or brain) 9 . By contrast, germ cells (oocytes or sperm) are terminally differentiated cells incapable of mitotic self-renewal in vivo. Although methods of derivation and maintenance in cell culture for somatic cells are very well established, the derivation and culture of oocyte-derived hESCs has only recently been achieved [10] [11] [12] [13] (also see preview by Sagy and Benvenisti 14 ). Here, we detail an experimental protocol for the derivation, maintenance and use of mouse hESCs.
Development and applications of the protocol
The haploid budding yeast (Saccharomyces cerevisiae) has been used for a long time as a model organism for genetic experiments, as its genome can be easily manipulated for targeted or random mutagenesis 15 . In vivo, mouse N-ethyl-N-nitrosourea mutagenesis was until recently the only method used to perform random mutagenesis screens in mammalian haploid cells 16 . Although very informative, these screens require extensive resources, space and time for phenotypic mutants of interest to be identified. More recently, the discovery of KBM7, a near-haploid leukemic cancer cell line 17, 18 , and its further engineering to remove one extra copy of chromosome 8 (ref. 19 ) and parts of chromosome 15 (ref. 20 ) created the HAP1 cell line, representing the first human cell line with a haploid genome to be propagated in culture. Limitations of the HAP1 cells relate to their transformed nature and the presence of various genomic alterations, including the BCR-ABL1 translocation, confounding some studies that aim to understand physiologic genetic pathways in normal cells.
In vitro activation of oocytes for parthenogenetic embryogenesis and later generation of hESCs was initially done in the 1920s by Pincus, who observed that some unfertilized rabbit oocytes could spontaneously undergo variable degrees of development that were morphologically indistinguishable from the development of fertilized oocytes 21 . Subsequent work expanded on these methods in mouse models and showed that exposing a mouse oocyte to electric-or hyaluronidase-mediated activation mimics fertilization and promotes cell division toward the formation of parthenogenetic blastocysts containing a mixture of haploid and diploid cells 22, 23 . Further elaboration on the methods of oocyte activation in mouse showed that this can be achieved in many ways, from spontaneous activation upon mechanical handling to thermal, electric or chemical activation 24 . Ultimately, investigators showed strontium chloride (SrCl 2 ) to be the only known parthenogenesis-activating agent that induces repetitive intracellular calcium releases [25] [26] [27] in a manner similar to those following normal fertilization by spermatozoa 28 . Moreover, it was observed that parthenogenesis may occur spontaneously in mice 29 and women 30 , leading to the generation of benign ovarian teratomas composed of a mixture of diploid and haploid cells, thus highlighting how haploid cells can persist after parthenogenesis. Collectively, these observations led to the development of methods for oocyte activation, growth and expansion of parthenogenetic blastocysts and subsequent isolation and maintenance of haploid mammalian ESCs from the mouse 10, 11, [31] [32] [33] , the monkey 34 , the rat 35 and the human 12, 13 . Analogously, by transferring sperm into an enucleated oocyte, haploid androgenetic ESCs have also been derived 36, 37 . Parthenogenetic hESCs are fully competent for functional contribution to the germline 38 . The generation of mouse and human hESCs has opened the door to functional random mutagenesis screens 39 that have shown that these cells can be successfully used, for example, for the identification of loss-of-function and separation-of-function mutants via approaches such as ethyl methanesulfonate mutagenesis 40, 41 , clustered regularly interspaced short palindromic repeats (CRISPR) screens 33, 42, 43 or transposon-induced mutagenesis 42 . The use of haploid cells in point mutagenesis screens opens an important avenue for identification of separation-of-function mutants 40 . Using hESCs in CRISPR screens allows higher efficiency, as one confounding factor in such genome-wide approaches in diploid cells is the presence of heterozygous deletions. Moreover, the hESCs are amenable to differentiation in different cell types, which in the future will allow screening in a multitude of cell lineages 43 . Furthermore, the generation of such cells allowed the creation of a cell bank (Haplobank: https://www.haplobank.at) of >100,000 publicly available individual mouse hESC lines carrying conditional and reversible disruption events in 16,970 mouse genes j PAUSE POINT Cells can be kept at -20°C for weeks.
11 Centrifuge for 5 min at 450g at RT and discard the supernatant. 12 Resuspend the cells in 0.5 ml of PI and transfer the cells to a FACS tube.
j PAUSE POINT Cells can be kept at 4°C overnight.
Procedure: flow cytometric analysis 13 Using the diploid control, acquire events with side scatter area on a linear scale (Lin) (SSC-A)-Lin versus forward scatter area (FSC-A)-Lin axes. The SSC-A-Lin versus FSC-A-Lin plot should reveal one population. Use the voltage and gain settings to center the main population and create the first gate (R1: ESCs) (Fig. 1a ). 14 Isolate doublets by plotting forward scatter width (FSC-W)-Lin versus FSC-A-Lin, and set gate R2 around single cells (Fig. 1b) . c CRITICAL STEP In the case of haploid/diploid cells, the doublet cell population will reveal two overlapping populations, haploid (n; below) and diploid (2n; above); when the first experimental sample is run, double-check that the haploid population is not excluded). 15 Isolate the live cells by plotting FSC-W-Lin versus PI stain to identify dead cells (left side) and events caused by autofluorescence (right side) and remove them by setting gate R3 on the PI population (Fig. 1c) . c CRITICAL STEP In the case of haploid/diploid cells, the doublet cell population will reveal two populations overlapping at the 100k mark: haploid (n; at 50k-100k) and diploid (2n; 100k-225k); when the first experimental sample is run, double-check that the haploid population is not excluded. 16 On Count-Lin versus PI-Lin axes, resolve the cell cycle profile. Acquire at least 10,000 events. On a cell line that contains a mix of haploid/ diploid cells the following will be evident ( Fig. 1d ):
• Haploid G1 phase of the cell cycle (hG1) at the 50K mark • Haploid S phase of the cell cycle (hS1) between the 50k and 100k marks • Overlapping haploid G2 phase of the cell cycle (hG2) and diploid G1 phase of the cell cycle (dG1) populations at the 100k mark • Diploid S phase of the cell cycle (dS) between 100k and 200k marks • Diploid G2 phase of the cell cycle (dG2) at the 200k mark Figure 2a shows the cell cycle profiles of three random WT clones c CRITICAL It is critical to first run the diploid-only control to recognize the diploid cell cycle peaks. Some experimental samples might be pure haploid populations, and without a diploid control, it will be impossible to tell them apart. 17 Save the experiment settings and experimental analysis on the flow cytometer.
observations of ESCs derived from fertilized embryos 45, 46 . In addition, the experimenter needs to keep in mind that the parthenogenetic hESCs derived from oocytes will always contain an X chromosome and never a Y chromosome.
Box 3 | Sorting of hESCs • Timing 1 h
Before preparing for the sort, bear in mind that you should always have a fully diploid control ESC cell line available to stain side by side to be able to calibrate the cell cycle profiles on the sorting machine. Before starting the cell harvest procedure, fill two Falcon round-bottom tubes to the edge with warm DMEM culture medium (from Step 52) and leave them at RT in a hood for at least 30 min (the serum from the medium will prevent the sorted cells from sticking to the walls and not being collected in the collection medium). Gelatinize T75 flasks using 5 ml of 0.02% gelatin solution each for 5 min. Prepare a bucket of ice to store and transport the cells to and from the sorter. Reagent setup FACS buffer. FACS buffer is 0.5% BSA in 1× PBS. The solution can be stored for up to 1 month at 4°C. Hoechst working solution. Hoechst working solution is 1 µg/ml Hoechst in DMEM culture medium (e.g., add 1 µl of 10 mg/ml Hoechst 33342 stock for each 100 µl of DMEM culture medium). Make fresh.
Procedure
1 Wash the cells with 1× PBS, trypsinize them using 1 ml of trypsin-EDTA and take up the cells in DMEM culture medium (10 ml for a T75 flask)
by pipetting up and down a couple of times. 2 Use 30-µm filters to remove cell clumps; filter into a new 15-ml conical tube. 3 Spin the tube down at 450g for 5 min at RT; discard the supernatant and resuspend in appropriate volume of NDiff N2B27 culture medium (0.5-ml minimum for a T25 flask or 1-ml minimum for a T75 flask). 4 Prepare Hoechst working solution in DMEM culture medium (e.g., 3 µl in 300 µl of DMEM culture medium). c CRITICAL STEP For some applications, such as point mutagenesis screens, it is advised to avoid the use of Hoechst dye for setting up the gates and instead to sort by size only. 5 For each milliliter of cell suspension, add 100 µl of 1 µg/ml Hoechst working solution to a final Hoechst concentration of 10 µg/ml. Incubate the mixture in the tissue culture incubator for up to 30 min (at 37°C, 5% CO 2 ) with gentle resuspension every 10 min. 6 (Optional) If you wish, add verapamil (an inhibitor of calcium pumps and hence any G1 to S transition) to the staining buffer to promote the identification of hG1 phase cells. 7 Filter into a new flow cytometry tube using 30-µm filters to remove cell clumps. Aspirate the media from the collection tubes, allowing 0.5 ml of residual medium in each tube and transport the collection tubes, the diploid control tube and the sample tubes to the sorting machine for sorting. Sorting can take 2-3 h (depending on how many cells are sorted). c CRITICAL STEP As with any cell sorting protocol, make sure the sorting machine is clean before sorting so that contamination with other cells or pathogens is avoided. 8 Align the optical light path of the flow cytometer before cell analysis using 3-µm beads (Sphero Rainbow Fluorescent particles) with a minimum peak coefficient of variance for all fluorescence channels. c CRITICAL STEP In parallel, stain as above the same (isogenic) cell line that has been allowed to diploidize previously. Using small aliquots (e.g., 100 µl), prepare a 1:1 mixture from the haploid line for sorting and the isogenic diploid line. This step will allow the clear differentiation between haploid/diploid populations. 9 Sort the G1 haploid population, following the gating strategy depicted in Fig. 3 and collect as many cells as possible. Haploid cells can be sorted as single cells in individual wells of 96-well plates. The clones selected this way have different haploid latency times (Fig. 3d) . If, for downstream experimental purposes (e.g., point mutagenesis), the use of Hoechst dye is not desired, establish the gates with a small subpopulation of Hoechst-stained cells, and then sort the bulk of the cells by size (mouse hESCs are approximately half the size of diploid isogenic ESCs). Precautions must be taken to avoid mistakenly gating out the diploids as doublets. c CRITICAL STEP Sort the bulk of the hG1 population and avoid the sub-hG1 population, which might contain cells that have lost chromosome X (mESCs are reported to randomly lose the X chromosome 46 ). 10 Spin the sorted cells down (450g, 5 min at RT) and resuspend in hESC medium. 11 Plate the cells in appropriate flasks or dishes containing hESC medium and allow for recovery. c CRITICAL STEP The hESCs can be sorted as a bulk population or as single-cell clones. Although the sorting of a bulk population reliably obtains almost pure haploid populations, sorting of individual cells has different rates of success due to the long time these cells have to be in culture before they can be expanded for banking. An example of the haploid status of three individual clones from sorting three individual WT cells is presented in Fig. 3e .
Experimental design considerations
A workflow of the Procedure is outlined in Fig. 4 . Female mice should be matched by genetic background, and ideally the experimenter should start with no less than five individual mice. The use of mice should be compliant with local animal research regulations as well as the ARRIVE guidelines 47 . If the derivation is done from specific knockout lines, to obtain both WT control and mutants in the same derivation, heterozygous mice should be used. Although an elaborate technique, by following the procedure described herein, the derivation of hESCs is highly reproducible.
Materials

Biological materials
• Female mice, ideally between 3 and 6 weeks of age (e.g., C57BL/6J mice; The Jackson Laboratory, stock no. 000664) ! CAUTION All procedures performed on mice must be carried out following national and In the case of the haploid/diploid cells, the doublet cell population will reveal two overlapping populations, haploid (n; below; note that as explained in the text using the right controls this population can be sorted by size only without the use of a dye) and diploid (2n; above). c, The live cells are identified by plotting gate R3 on FSC-W-Lin versus PI to identify and isolate dead cells (left side) and events caused by auto-fluorescence (right side). d, Representative cell cycle profile of a clone that contains a mix of haploid and diploid cells. On Count-Lin versus PI-Lin axes the following cell cycle phases can be identified: the haploid G1 phase of the cell cycle (hG1), the haploid S phase of the cell cycle (hS1), the overlapping haploid G2 phase of the cell cycle (hG2) and diploid G1 phase of the cell cycle (dG1), the diploid S phase of the cell cycle (dS) and the diploid G2 phase of the cell cycle (dG2). FSC-A, forward scatter area; FSC-W, forward scatter width; SSC-A, side scatter area.
institutional guidelines. In the UK, Home Office regulations must be followed with appropriate establishment, project and personal licensing in place. Experiments using mouse models should be performed in accordance with the ARRIVE guidelines 47 . Approval for our experiments was granted by the UK Home Office. 
Reagents
Fig. 2 | Qualitative control of the hESCs. a, Representative examples of the cell cycle profiles of three individual ESC cell lines at the first cell cycle analysis post derivation. Although some clones might be more stable and thus highly enriched for hESCs (left), most will be a mix of haploid/diploid cells (middle), whereas some will be more unstable and be fully diploid (right). b, Fluorescent in situ hybridization analysis of a representative haploid clone shows a stable n = 20 karyotype (scale bars, 5 µm). ; care must be taken so that diploids are not mistaken as doublets. We recommend use of a 1:1 haploid/diploid isogenic mix to set up the gates. c, The cells gated on R2 are subsequently resolved on an FSC-H-Lin versus FL4-H: Hoechst-Lin plot and the haploid G1 (hG1) population is identified and sorted using gate R3. Gate R3 is built tightly around the hG1 peak to avoid sorting of cells with lower DNA content (which might be due to aneuploidy). d, The profile of the hG1 (gate R3) on the Count-Lin versus FL4:Hoechst-Lin representing the cell cycle profile. e, Graph presenting the percentage of hG1 over time for three individual WT clones derived by individually sorting from the same WT line. Data were obtained by flow-cytometry profiling using PI. 10,000 cells (events) were acquired for each cell line at each time point. FL4-H, intensity (height) in the FL4 channel: Hoechst; FL4-W, intensity (width) in the FL4 channel: Hoechst; FSC-H, forward scatter height; Lin, linear scale; SSC-H, side scatter height; WT, wild-type.
• GSK3 inhibitor: CHIR99021 (CHIR; Abcam, cat. no. ab120890) ! CAUTION CHIR is acutely toxic if swallowed and an irritant. Consult safety and hazard sheets provided by the seller. • EGTA Prepare 0.5 M EGTA using an analytical balance with precision of 0.1 mg to weigh 234 mg of EGTA tetrasodium and add it to 1 ml of KSOM medium. pH adjustment of the EGTA solution is important; the pH will initially be~10. Add 1 M HCl to the 1 ml of EGTA solution in increments of 200 µl, adding a total of 600 µl and using the pH meter to ensure the pH = 8. Make up fresh and use within 24 h. Store at 4°C.
Oocyte activation medium
Add 150 µl of 100 mM strontium chloride hexahydrate solution and 12 µl of 0.5 M EGTA to 3 ml of KSOM medium and filter-sterilize. Store at 4°C for use the following day or put 2 ml in a 60-mm center-well culture dish, surrounded by PBS in the outer well, and pre-equilibrate to 37°C for use on the same day.
Hyaluronidase solutions Make a stock solution of hyaluronidase by adding 3.53 ml of M2 to 100 mg of lyophilized powder. Gently agitate the solution, ensuring that the powder is fully dissolved. Make working concentrations by adding 100 µl of the 30 mg/ml stock hyaluronidase solution to 900 µl of M2 to create a 3 mg/ml solution. Filter-sterilize, divide into 200-µl aliquots and store at -20°C for up to 1 year. For use in removal of oocyte cumulus cells, add one 200-µl aliquot of the solution to 1.8 ml of M2.
Pregnant mare's serum gonadotropin Prepare PMSG in a clean class 2 safety cabinet. Reconstitute the 5,000 international units (IU) of lyophilized powder by mixing it with 80 ml of PBS, ensuring that the powder is completely dissolved. Divide the solution into 1.5-ml aliquots and store at -20°C to use for up to 3 months.
Human chorionic gonadotropin
Prepare HCG in a clean class 2 safety cabinet. Reconstitute the 1,500 IU of lyophilized powder by mixing it with 30 ml of PBS, ensuring that the powder is completely dissolved. Divide into 1.5-ml aliquots and store at -20°C to use for up to 3 months.
NDiff N2B27 culture medium To 94 ml of NDiff N2B27 media, add 5 ml of 7.5% BSA, 1 ml of penicillin-streptomycin (100×), 10 µl of LIF, 1 µl of 2-mercaptoethanol, 2i (10 µl of PD (10 mM stock; stored at 4°C) and 30 µl of CHIR (10 mM stock; stored at -20°C)). NDiff N2B27 culture medium can be stored at 4°C for up to 1 month. ! CAUTION 2-Mercaptoethanol is classified as a severely toxic chemical and a DNA mutagen. Consult safety and hazard sheets provided by the seller; use only under a chemical cabinet.
DMEM culture medium
To 500 ml of DMEM high-glucose medium (1 bottle), add 75 ml of FBS, 6 ml of NEAA (100×), 6 ml of sodium pyruvate (100 mM), 6 ml of penicillin-streptomycin-glutamine (100×), 60 µl of LIF, and 6 µl of 2-mercaptoethanol. (Optional) If 2i addition is required (see Procedure), add 60 µl of PD (10 mM stock; stored at 4°C) and 180 µl of CHIR (10 mM stock; stored at -20°C). DMEM culture medium can be stored at 4°C for up to 1 month. ! CAUTION 2-Mercaptoethanol is classified as a severely toxic chemical and a DNA mutagen. Consult safety and hazard sheets provided by the seller; use only under a chemical cabinet.
0.02% Gelatin solution
Allow 2% (vol/vol) gelatin solution to completely liquefy at 37°C and make a 0.02% gelatin working solution with 1× PBS (e.g., 5 ml of 2% gelatin in 500 ml of 1× PBS). The solution can be stored for up to 1 year at room temperature (RT; 20-25°C).
Equipment setup
Stereomicroscope with heated stage Manipulation of embryos is done using a stereomicroscope with heated stage and a zoom capacity of up to 100× magnification.
Humidified incubator
Incubation of oocytes in oocyte activation medium and all subsequent culture is done in a humidified incubator set to 37°C, 5% CO 2 .
Procedure Superovulation • Timing 30-40 min
1 Identify female mice to use as donors for oocyte production and set aside in advance. The mice should be superovulated between the ages of 3 and 4 weeks. ! CAUTION All procedures on mice must be carried out in accord with relevant local and national regulations. In the UK, this means in accordance with Home Office regulations and with appropriate establishment, project and personal licensing in place. c CRITICAL STEP Note that the best age for superovulation varies from strain to strain but usually lies between 3 and 6 weeks of age, during the prepubescent stage of development 48 .
2 Inject the mice at 3 PM, removing the PMSG hormone (6.25 IU, 0.1 ml for each female mouse) from the freezer 15-20 min before the injections are scheduled, in order to allow the hormone to defrost and warm to RT. 3 Once completely defrosted, draw up the hormone into a 1-ml syringe, making sure there are no air bubbles in the syringe. Attach a 27-gauge needle to the syringe, hold it with the needle facing up and depress the syringe plunger to expel air from the dead space created. 4 Scruff the mouse and turn it so its stomach is facing upward and its head is slightly tilted back. 5 With your free hand, hold the syringe so the needle is bevel side up. Carefully insert the needle into the peritoneal cavity of the mouse, to the left or right of the midline of the mouse, making sure not to hit the bladder. 6 Following your approved technique for mouse i.p. injection, administer 6.25 IU of PMSG (0.1 ml).
After preparing the PMSG solution, we draw it up into the syringe, keeping in mind the dead volume in the needle. We gently remove the animal from the cage and restrain appropriately in the head-down position. We disinfect the lower right quadrant of the abdomen with 70% ethanol and inject by inserting the needle with the bevel facing up at an~30°angle to horizontal, toward the head in order to avoid damage to the urinary bladder, cecum and other abdominal organs. We wait briefly before withdrawing the needle, to make sure the liquid does not seep out. 7 Place the mouse into an empty cage and then repeat Steps 5 and 6 for each mouse until finished.
Once all mice have been injected, they can then be returned to their original cages. 8 Dispose of the needle and syringe in a sharps bin.
! CAUTION Extreme caution is required at all times when handling used sharps. Dispose of sharps directly without capping. 9 46-48 h after PMSG administration, repeat Steps 2-8, but inject with 5 IU of HCG (0.1 ml), rather than PMSG.
Dissection and oocyte removal • Timing 50-60 min
10 Set up four single Falcon center-well culture dishes per line: one containing oocyte activation medium and three with KSOM medium for washing. There should be 1 ml of respective culture medium in the center well, with 2-3 ml of DPBS in the outer well. 11 Filter 10 ml of M2 into a Falcon tube, using a 0.22-µm filter, and place the tube in an incubator to warm to 37°C. 12 Remove one vial of hyaluronidase (working stock solution) from the −20°C freezer and thaw it in an incubator, warming to 37°C. 13 Place a 50-mm dish containing 2-3 ml of M2 or 0.9% DPBS on a heat blanket or warming stage set to 37°C. 14 Cull a female by cervical dislocation and lay the mouse on its back, exposing the abdomen. 15 Make a midline incision up and through the abdominal wall, followed by the peritoneal sac, to expose the internal organs, pushing the gut up and out toward the chest and revealing the reproductive organs. 16 Grasp the upper end of one of the uterine horns with fine forceps and gently pull the uterus, oviduct, ovary, and fat pad taut and away from the body cavity. This will reveal a fine membrane, the mesometrium, which connects the reproductive tract to the body wall and carries a prominent blood vessel. Make a hole in the membrane close to the oviduct with the closed tips of a pair of fine forceps or scissors. 17 Reposition the forceps and cut the uterus near the oviduct. 18 Transfer the oviduct and attached segment of uterus to the 50-mm dish containing DPBS at 37°C. c CRITICAL It is important to keep oocytes at 37°C at all stages in order to maintain oocyte viability and the chance of successful parthenogenesis. 19 Repeat Steps 14-18 for all females; oviducts from several mice can be collected in the same dish. 20 Prepare a 35-mm dish containing 2 ml of filtered M2 for washing oocytes after exposure to hyaluronidase. Keep the dish at 37°C. 21 Pipette 1.8 ml of the pre-warmed M2 into a 35-mm culture dish. 22 Move 1× oviduct into the dish with the 1.8 ml of filtered M2 and 'pop' the swollen ampulla to release the cumulus mass, then discard the oviduct. Repeat until all oviducts have been processed (Supplementary Video 1) .
23 Add all the hyaluronidase working stock solution from the vial and gently swirl/agitate the dish to help disperse the cumulus mass or pipette up and down gently several times with a 1-ml tip, then wait for the cumulus cells to start falling away, leaving individual oocytes. c CRITICAL STEP Hyaluronidase can have a detrimental effect on the oocyte, so the oocytes should be collected and washed quickly. Reducing the amount of hyaluronidase added to the M2 will increase the time it takes the embryos to become free from cumulus cells but will allow more time for users less familiar with the protocol to collect the oocytes. 24 Pick up the individual oocytes with a transfer pipette and place them into the 2 ml of warmed M2, repeating until all oocytes are collected. 25 Wash the oocytes through 6× drops of pre-warmed, filtered M2. Once washed, the oocytes can be kept together in a drop of M2 and assessed for viability. ? TROUBLESHOOTING 28 Transfer all viable oocytes to the pre-incubated oocyte activation medium and place the plate in a tissue culture incubator for 90 min at 5% CO 2 , 37°C. c CRITICAL STEP Viable oocytes must be placed in to the oocyte activation medium for the stated time and without delay to optimize chances of successful parthenogenic activation. 29 Remove the oocytes from the oocyte activation medium by gently mouth pipetting and wash by successive placement in three dishes of pre-equilibrated KSOM medium. 30 Observe the oocytes for polar body extrusion, which indicates successful activation. Once the oocytes are in the oocyte activation medium, it takes up to 90 min for all the oocytes to become activated (polar body extrusion). 31 Culture the oocytes for 72 h.
Selection of blastocysts • Timing 2-3 d
c CRITICAL This section of the protocol is outlined in Fig. 5 . 32 On day 3 post activation, the embryos will be at a variety of developmental stages: some embryos will appear subviable and some may have lysed (Fig. 5a ). Remove lysed embryos, but retain those in which the cells have not divided cleanly, as they may still progress to blastocysts. 33 Move 8-cell embryos to KSOM medium supplemented with 2i (CHIR (3 µM) and PD (1 µM)), pre-equilibrated to 5% CO 2 , 37°C and continue to culture. 34 On day 4, there will be some embryos that have developed to blastocysts that are suitable for zona pellucida removal (Fig. 5b) . Select only embryos that have a well-expanded blastocoel for zona removal. 35 Repeat Steps 32-34 (the check and selection of blastocysts for zona removal) on days 5 and 6 (Fig. 5c ).
Zona pellucida removal • Timing 30 min
c CRITICAL When handling embryos, process one line at a time to make sure that strains do not become mixed, and label all dishes and vials containing embryos with strain information or a unique identifier. 36 Pre-warm acidic Tyrode's solution to 37°C.
37 Put two~200-µl drops of acidic Tyrode's solution and two~200-µl drops of M2 on a dish suitable for working under a stereomicroscope. 38 Select the blastocysts for zona removal and move to one of the M2 drops.
c CRITICAL STEP Most blastocysts should be available for zona pellucida removal on this day. Move the remaining embryos into fresh, pre-equilibrated KSOM medium for further culture. a, On day 4 after removal and activation, embryos will be at a variety of developmental stages, with some embryos appearing subviable and some lysed (left: Before sort). Upon removal of subviable or lysed embryos, only the embryos that show viable characteristics are retained (right: After sort). b, On day 5, the embryos that have developed to blastocyst and are suitable for zona pellucida removal are identified. Select only embryos that have a well-expanded blastocoel for zona removal. c, The check and selection of blastocysts for zona removal is repeated on day 6 (representative image). d, Representative image depicting the morphologic aspects of blastocysts after zona removal (days 6-9). These individual embryos are transferred to 96-well plates at this point. e, Representative image of a colony that has formed from a post-denuding blastocyst and that is ready for dissociation using trypsin-EDTA. f, Representative image of an established hESC clone/cell line that is ready for quality control. Scale bars, 250 µm.
40 Briefly pipette the blastocysts up and down with a mouth pipette to ensure the zona is completely removed and transfer the blastocysts to the second drop of M2 (Supplementary Videos 3 and 4). 41 Observe the blastocysts in M2 and manipulate them with a new mouth pipette to check that the zona has been completely removed ( Fig. 5d; Supplementary Video 4) . If the zona remains intact after inspection, repeat Steps 38-41, using a second drop of acid. 42 When the zonae have been removed, immediately transfer the blastocysts to a fresh dish of M2.
? TROUBLESHOOTING 43 Wash the blastocysts through an additional two dishes of M2. 44 If transporting the blastocysts, pipette 50 µl of M2 into a 1.5-ml microcentrifuge tube and label it with strain and embryo number. Using a mouth pipette and M2, load an air bubble to be positioned behind the blastocyst and transfer embryos to the vial. The bubble behind the blastocysts should come from the pipette, indicating the blastocysts have been deposited in the vial. ? TROUBLESHOOTING 47 Culture the embryos until they grow into visible cellular colonies (~1 mm in size; this takes up to 10 d in culture) (Fig. 5e ). c CRITICAL STEP Pay particular attention to retaining the colony if medium change is required (if the medium starts to become yellow in color), as the colony will not attach strongly to the bottom of the dish. 48 Transfer a unique colony to 15 µl of trypsin-EDTA and, after 2-3 min, pipette up and down, using 15 µl of DMEM culture medium to inactivate the trypsin-EDTA, and transfer to another well of a 96-well gelatin-coated plate containing 250 µl of NDiff N2B27 culture medium. ! CAUTION hESCs diploidize faster in DMEM culture medium than in NDiff N2B27 culture medium. Do not try to spin down the cells after trypsinization, as it is very easy to lose the lines when doing this. c CRITICAL STEP Most blastocysts will have expanded to cellular colonies by this point, but some might need additional days of culture. 49 In 3 d, or upon confluency, trypsinize the cells as described in Step 48 and re-plate in a gelatincoated 24-well plate; at this point the hESCs will form colonies (Fig. 5e) . ? TROUBLESHOOTING 50 In 3 d, or upon confluency, again trypsinize as described in Step 48 (increasing the trypsin-EDTA volume accordingly to cover the bottom of the well; e.g., 50 µl of trypsin-EDTA) and block trypsinization with an equal volume of DMEM culture medium. Transfer the cells to a gelatincoated 6-well plate; at this point, flow cytometry cell cycle analysis can be performed to assess the haploid status of each clone (Box 1) ? TROUBLESHOOTING 51 In 3 d or upon confluency, trypsinize the cells yet again as described in Step 48 and transfer them to a gelatin-coated 10-cm dish or T25 flask. The first sorting for haploid enrichment can also be performed (Box 3). Plate sorted cells in a gelatin-coated T25 flask. 
Troubleshooting
Troubleshooting advice can be found in Table 1 .
Timing
It is recommended that the superovulation be scheduled for Tuesday and Thursday, with injections at 3 PM, as this allows mouse dissection, oocyte removal and activation on a Friday, followed by embryo culture over the weekend and assessment for blastocysts during the weekdays of the following week. 
Box 4 | The Haplobank and gene trap flipping
The Haplobank (http://www.haplobank.at) contains >100,000 cell lines covering~17,000 genes in the mouse genome and thus represents the largest homozygous ESC library available to the scientific community to date 42 . These cell lines are on/off systems that allow for conditional induction of gene disruption and subsequent reversal, permitting fast complementation to be performed for validation. Moreover, these mutants were engineered in single cell-derived clones and are thus isogenic, therefore allowing improved reproducibility across different comparisons, not only in one laboratory, but across the scientific community. Such a resource will permit the broad and robust interrogation of the functional genome. Below we highlight information to help with decision making when selecting clones from the Haplobank website and provide a protocol for gene trap flipping. The constructs used for disruption are presented in Supplementary Fig. 1a , and their sequences are available as Supplementary Data.
Decision points: selection of clones from the Haplobank website for an insertion in the first intron (1 intron). Keep in mind that a mutation in the coding sequence is phenotypically irreversible.
• Upstream, InterDown and InterUp carry the gene trap in an intergenic region and cannot be regarded as knockouts • The choice of the mutagen is then the last thing: Tol2GT/Retro/Lenti are enhanced gene traps, whereas Tol2 is a polyA-enhanced gene trap that carries EGFP • The insertion site is predicted with high certainty to be disruptive for all RefSeq transcripts of this gene. The splice acceptor is integrated into a genomic locus common to all RefSeq transcripts (intronic and exonic) and before 50% of the longest open reading frames • Integration sites were identified using three different approaches: two inverse PCRs using the two different restriction enzymes, E1
( Supplementary Fig. 1b , Tables 2 and 3 ) and a barcode PCR, all followed by NGS. If the mapping strategy was successful, it has a green light Procedure c CRITICAL Gene trap cassettes harboring disruptive splice acceptor sites are integrated either in sense or antisense relative to corresponding gene transcripts. This will lead to disruptive or non-disruptive integrations, respectively. Inverted LoxP and FRT sites flank the gene trap cassette, enabling the orientation to be reversed twice, by transiently infecting cells with Cre or Flp recombinase-expressing plasmids (double-flex system). A thereby-generated isogenic sister clone can be used as a perfect internal control. For the production of retrovirus containing the Cre-or Flp-expressing vector, the Cre/Flp-expressing plasmid should be linked with a selection marker (e.g., mCherry, Cre-puro) to evaluate infection efficiency and/or select for infected cells. c CRITICAL Before infection, the ESCs should be propagated by standard procedures and should be passaged several times before infection and/ or sorted for haploid content if desired. The maps of these constructs are presented in Supplementary Fig. 1 and the respective sequences in Supplementary Data. 1 3-4 h before infection, seed~250,000 cells per 6-well plate or 50,000 cells per 24-well plate for infection in triplicates. 2 Distribute the viral supernatant on the ESCs. Infection efficiency can be increased by adding 2 µg/ml polybrene to the culture medium. Alternatively, if you use a frozen virus stock, thaw an aliquot (on ice) and recalculate infection efficiency using the chosen selection marker (e.g., mCherry, Cre-puro). 3 8-12 h post infection, exchange the media. Check infection efficiency by flow cytometry 48 h post infection or change to selection media and select until selection control wells are empty (e.g., with puromycin, it takes 2-3 d). 4 Confirm the successful inversion of the gene trap cassette by PCR or western blot for the target gene. Various vectors can be used to stably integrate gene trap cassettes into genomic DNA of haploid cells. Among them, virus is most commonly used. However, integration sites for viral integrations cluster strongly and thus result in poor genome saturation 42 . Moreover, integration sites relative to gene bodies vary for different vector systems. Transposon mutagenesis is an attractive alternative method for integrating gene trap vectors into genomes, as it not only achieves better genome saturation, it also circumvents virus work and associated risks. Single transposon integrations are generated only by strongly compromising on integration efficiency. When electroporating for complex library preparation (e.g., to generate 50 million independently mutated cells), the experimenter needs to electroporate at least 50 independent reactions. Using Tol2 transposons achieves good single-integration events at 0.5 µg of transposon plasmid and 10 µg of transposase plasmid; however, this may vary depending on transposon system and transposase variant, electroporator, cell line and medium conditions. The challenge for transposon mutagenesis is to achieve single integration events for each cell. Electroporation of DNA is best suited to single integrations; nevertheless, careful titration of transposon containing plasmids must be undertaken. The following protocol describes one possible approach, namely use of an AMAXA 2D electroporator (Equipment) and a Mouse ES cell Nucleofection Kit (Reagents). The workflow is outlined diagrammatically in Fig. 6 . expertise. We recommend the use of an NGS facility.
Additional reagents
Reagent setup
Genomic DNA lysis buffer. Genomic DNA lysis buffer is 10 mM Tris-HCl, pH 8.0; 5 mM EDTA;100 mM NaCl; 1.0% SDS. The buffer can be stored at RT for up to 6 months. 1 mg/ml proteinase K should be added fresh.
Procedure for electroporation of gene traps and screening 1 Expand hESCs using standard conditions and sort for haploid cells (Box 3) a few days before electroporation. 2 Harvest the cells by trypsinization, stop trypsinization by adding 10 ml of culture medium and centrifuge the cells using a 15-or 50-ml centrifuge tube, depending on cell volume, for 5 min at 20g at RT. 3 In the meantime, prepare electroporation cuvettes and set the electroporator to program A-013. (Alternative programs suggested by the supplier can also be tested.)
4 Prepare and label cell culture dishes, then fill them with ES cell medium. 5 Aspirate the supernatant, take up the cell pellet in 1× PBS, and count the cells. 6 Add 7 million cells each to independent 15-ml centrifuge tubes and fill up with 1× PBS to 15 ml. Use one tube per planned electroporation plus one tube for a control. 7 Centrifuge the cells for 5 min at 20g at RT. In the meantime, prepare DNA solutions (step 8). 8 In separate 1.5-ml tubes, mix 90 µl of electroporation mix (also see manufacturer's notes), 10 µg of transposase containing plasmid, and various amounts of transposon containing plasmid. We recommend testing 0, 0.25, 0.5, 1, 2.5 and 5 µg. Ensure that the total added volume does not exceed 10 µl. If the volume is between 10 and 20 µl, add 10× PBS at 1/9 of the volume of DNA. The total volume should not exceed 20 µl. 9 Aspirate 1× PBS from the ES cell-containing tubes. Briefly centrifuge the tubes at 100g for 10-20 s at RT and fully aspirate the 1× PBS. 10 Take up DNA solution and use it to carefully resuspend the cell pellet and immediately place the cells in an electroporation cuvette. 11 Electroporate the cells. 12 Carefully aspirate the cells from the cuvette, using the provided plastic Pasteur pipette, and pipette directly into the cell culture medium of a prepared dish. 13 24 h post electroporation, begin antibiotic selection for integration events. Upon completion of selection, the cells can be used for cryopreservation and usage at a later time point.
Library preparation and sequencing For library preparation, enzyme 1 (E1) is used to fragment the genome ( Table 2 ). Because the recognition sequence for E1 is also present in the terminal repeat of the gene trap vector, it is possible to retrieve the exact integration site of the gene trap cassette within the genome by circularizing E1-digested genomic DNA (ring ligation) and subsequently amplifying the genomic region by inverse PCR (iPCR) using primers 'US' and 'DS' (see Tables 2 and 3 and Supplementary Fig. 1b ). To improve iPCR efficiency, a linearization step using E2 should be used, which re-opens the rings generated previously. Moreover, each integration site can be mapped using two different E1 enzymes. We recommend splitting the samples and using both E1 enzymes on each sample in parallel. The directionality of the mapping strategies for different gene traps is important, as this affects the assignment of a particular insertion to the sense and antisense strands in the genome, respectively. The DS primer is common for all PCR reactions, and binds in the gene trap. The US primer contains a sequence that will bind to the oligo present on the NGS flow cell surface, an index of 4-8 bases, and then a sequence that binds in the gene trap.
The mutagenesis systems and enzymes used are shown in Table 2 , and iPCR primer sequences used for library amplification and sequencing are shown in Table 3 . The INDEX is a custom barcode (4-8 bp) that allows the unique identification of all the PCR reactions from one complex sample. For each sample, two different US primers with two different indices need to be used: one for the PCR reaction of the genomic DNA digested by E1-1 and one for the PCR reaction of the genomic DNA digested by E1-2. For NGS, all samples can be mixed and loaded into one NGS flow cell. The index sequence will allow the identification of the original samples. The workflow for library preparation is shown below.
Library preparation and sequencing procedure 1 Lyse the cell pellet according to pellet size in 2-10 ml of genomic DNA lysis buffer (see 'Reagent setup'). 
Statistical analysis
To increase reliability of the analysis for each biological replicate, two sequencing libraries should be constructed: one for sequencing into the adjacent genome 5′ of the insertion site, and one for sequencing into the 3′ adjacent genome. Pearson correlation should be used to compare the read counts obtained by sequencing the two libraries and should allow reliable identification for each insertion. The statistical analysis can be done using the R framework 51 to map the reads for each insertion site, and Gaussian kernel convolution 52 can be used to identify common insertion sites. By using co-occurrence analysis in R and using a Fisher's exact test, the overlap of common insertion sites across the biological repeats can be examined to identify strong gene candidates. For each gene, the insertion sites can be mapped to identify position and direction of insertions across the gene body (e.g., gene X). These candidates can be subsequently used for DAVID analysis 53 to generate a network of genes nodes, with the node sizes being representative of the total number of common insertion sites (Fig. 6d) .
Anticipated results
Typically, cells will undergo cell division before expression of transposase. Therefore, individual colonies appearing in the selection will very often be mixed colonies, with individual cells harboring independent integration events. Thus, to test for multiplicity of infection (MOI), pick colonies, trypsinize cells (of each condition) subsequent to completion of selection (days 5-7) and reseed them at clonal density (100 cells/10 cm dish, 500 cells/15 cm dish). Pick 20-50 colonies per condition at days 10-12 after reseeding and expand them in 96-well dishes. Genomic DNA can be prepared in bulk or in 96 wells, depending on screen setup using either genomic DNA lysis buffer or Qiagen DNeasy Blood & Tissue Kits. Optionally, acoustic shearing of DNA can be carried out using the Covaris system. It is most convenient to perform a PCR across a random barcode integrated within the transposon and then subject it to Sanger sequencing. Clean sequencing tracks are indicative of single integrations, whereas overlaid sequence tracks indicate multiple integration events. Please note that in the presence of transposase, transposons may be remobilized and integrated into a new genomic site. Even though these DNA transposons work via a cut-paste mechanism, mobilization in the G2 phase of the cell cycle can in some cases result in two independent transposon integration sites within a cell that carry the same random genetic barcode. Alternatively, perform iPCR to map integration sites. Note that efficiency of iPCR is only~80%, so some double integrations may be missed. For generation of complex pools of cells, proceed with screening for phenotypes of interest. Note that loss of protein may take up to 7-10 d for stable proteins in cases of late integration. The number and locations of integrated transposons per cell can be identified by library sequencing and analysis. Library preparation can be performed in various ways (see review by Elling and Penninger 39 ). We recommend the iPCR method described here, which we have successfully used 42 . Alternatively, transposon insertion site sequencing can be done by the QiSeq method as described by Friedrich and collaborators 49 . Before executing NGS, consider the expected complexity. You will receive 100-200 million reads from a single lane. As this is usually multiple times more than the complexity of your input, you might be oversampling the experiment. This can-by misalignment-cause artifacts. For that reason, it can be advantageous to combine several experiments in one lane by indexing. Subdividing single experiments is not advisable, as the data are not simply additive. To optimally use NGS, consider the scale of input and experiment. If you wish to quantitatively use the NGS data, the 200 million reads must stem from 200 million independent genomes. If the complexity of input is lower, the experiment can be scaled accordingly. The red arrow depicts a random integration event into a random gene (gene X) and points in the direction of integration. As the integration is achieved in an hESC, upon diploidization, the insertion will also be duplicated, thus always resulting in homozygous representation. In screening strategies using transposons but also CRISPR-Cas9, this represents an important advantage. b, Screening with transposon approaches relies on the electroporation of the transposon into the hESCs and selection of cells that have successfully integrated the constructs. After~10 d in culture to allow the respective proteins to be depleted, these cells can be subsequently used for different screening strategies in which a comparison between control untreated samples and treated samples is made. We recommend n = 4 technical replicates over two biological replicates for each group. c, Library preparation for inverse PCR (iPCR) requires digestion of the genomic DNA using enzyme 1 (E1). Upon digestion, the DNA containing part of the enhanced gene trap enclosing DNA fragments (pEGT; red) are ring-ligated, followed by digestion of the ring DNA constructs encompassing EGTs and subsequent next-generation sequencing (NGS). See also Supplementary Fig. 1b . d, Schematic representation of a possible screening outcome. The overlap between the common insertion sites across the four biological replicates can be represented as a Venn diagram. The enriched transposons (presumably one transposon on each cell) can be mapped to the respective genome locations for each gene. On the basis of this enrichment and statistical analysis across the technical repeats comparing the treatment groups to untreated groups, a gene ranking statistical score can be generated. The top candidate genes can subsequently be used for DAVID pathway analysis, for example, in which each gene circle size can be representative of the number of insertions. Moreover, mapping the insertions over the gene bodies can inform on specific clustering around the promoter or around a relevant domain region. For the statistical analysis, see also the protocol by Friedrick et al. 49 .
The protocol presented here will allow derivation and maintenance of mouse hESCs. Although the protocol for derivation of hESCs is lengthy (about 7 weeks), it allows reliable and reproducible derivation of hESCs. In our experience, mouse hESCs can be successfully established in gelatin-coated plates, with only minor improvements when deriving them on plates containing irradiated feeders. The bottleneck for successful cell line production is the quality of the embryos selected. This can vary depending on mouse strain, mouse age, handling of oocytes, choice of which oocytes to select, successful activation, subsequent choice of which blastocysts to select and successful zona pellucida removal. In our experience, from 1,534 oocytes, we had overall success rates of 1 blastocyst for each 10.5 oocytes (1 blastocyst for every 3.95 oocytes, if we do not include oocytes that do not progress within 24 h and that were unlikely to be viable in the first place). Our activation success rate is 1 per 2.65 oocytes and our average success rate for cell line production is 1 cell line for every 1.4 blastocysts used. Although there might be a minor advantage to using feeders, for users that do not have much experience with handling ESCs on feeders, culture without feeders is the most straightforward to undertake, as it allows easier identification of the hESC colonies. We recommend that before freezing down the cellular clones, a mycoplasma test be performed. We have not had any mycoplasma contamination so far.
The associated procedures allow the screening of clones that contain haploid populations (Box 1), karyotyping of the isolated hESC clones (Box 2) and sorting for enrichment of hESCs (Box 3). We also describe considerations for the use of hESCs imported from the Haplobank (Box 4; Tables 2  and 3 ). Haploid cells can be subsequently successfully used for genetic screens (see Box 5 and Fig. 6 for one such example) . Similar principles can be used for the maintenance and propagation of human hESCs.
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